ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,718Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 663

$441K Total Retail Price of All Prescriptions

Rank: 94 out of 663

490 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,259 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 715 587 1 1
LISINOPRIL 587 527 2 2
HYDROCHLOROTHIAZIDE 362 335 3 12
LEVOTHYROXINE SODIUM 332 301 4 3
METOPROLOL TARTRATE 309 283 5 11
AMLODIPINE BESYLATE 290 256 6 5
FUROSEMIDE 268 231 7 7
TRAMADOL HCL 255 193 8 17
WARFARIN SODIUM 229 164 9 8
OMEPRAZOLE 223 205 10 4
ALENDRONATE SODIUM 214 199 11 15
CITALOPRAM HBR 181 168 12 18
METOPROLOL SUCCINATE 179 144 13 25
METFORMIN HCL 178 153 14 9
POTASSIUM CHLORIDE 166 139 15 23
DONEPEZIL HCL 162 156 16 40
HYDROCODONE-ACETAMINOPHEN 151 120 S3 17 6
ATORVASTATIN CALCIUM 143 127 18 13
DOXAZOSIN MESYLATE 127 86 19 73
MIRTAZAPINE 116 115 20 52
GABAPENTIN 112 78 21 20
POLYETHYLENE GLYCOL 3350 99 40 22 82
FENTANYL 96 94 S2 23 75
ATENOLOL 95 80 24 10
TAMSULOSIN HCL 93 88 25 24
CARVEDILOL 77 65 26 47
LOSARTAN POTASSIUM 73 60 27 14
ADVAIR DISKUS 73 65 27 53
SERTRALINE HCL 72 71 29 35
GLIMEPIRIDE 71 58 30 84
FLUOXETINE HCL 67 54 31 32
VYTORIN 65 63 32 173
RANITIDINE HCL 60 47 33 31
SPIRIVA 59 47 34 62
OXYBUTYNIN CHLORIDE ER 57 57 35 121
CYMBALTA 57 56 35 54
ACTOS 57 35 35 105
LANTUS 56 21 38 48
DIGOXIN 55 55 39 50
OLANZAPINE 52 46 40 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.